Israel

Israel

MembersMerck Invests in Israeli Biotechnology

The German pharmaceutical company Merck, together with other international companies in the same line of business, plan to launch a fund that will invest 20 million euros ($24.6 million) in Israeli biotechnology over the next five years.

Photo: Nati Shohat/Flash90

Merck’s managing director, Stefan Oschmann, said in Israel: “The spirit that drives Israeli start-ups is unique and inspiring. We are proud to play an active part in this success story. We are now taking a further important step in our investments in Israel with our trust in the innovative potential of the country.”

Merck has been in existence since 1668, and is thus the oldest pharmaceutical company in the world. The company...

Israel Today Membership

Become a Member

  • Read all member content

    Get exclusive in-depth reports from Israel.

  • Get exclusive in-depth reports from Israel

    Connect with Israel, right from your home.

  • Lift up the voice of truth and hope

    Support Jerusalem-based Zionist journalism.

Already a member? .

About the author

Patrick Callahan

This is an example of author bio/description. Beard fashion axe trust fund, post-ironic listicle scenester. Uniquely mesh maintainable users rather than plug-and-play testing procedures.

Leave a Reply

Login